We found 3 drugmaker programs for Idiopathic Pulmonary Fibrosis medicines and 3 charity funds (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Idiopathic Pulmonary Fibrosis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays, premiums or other treatment costs.
Covers: Out-of-pocket costs for approved medications. Up to $7,000 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Esbriet Co-pay Program: eligible patients with commercial insurance may pay as little as $5 per 30-day supply of Esbriet, with up to $25,000 in assistance per calendar year. Not for state or federal health plans.
Legacy Patient Program: free Esbriet for eligible patients who are uninsured, whose insurance does not cover Esbriet, or whose out-of-pocket costs are high, with household income under $150,000 for 1 to 4 people. Call 1-866-435-8080.
Legacy Pharma took over US sales of Esbriet from Genentech on November 3, 2025, so Genentech's programs no longer cover it. Generic pirfenidone has been available since 2022.
Jascayd copay savings card: eligible patients with commercial insurance may pay as little as $0 a month. Not for Medicare, Medicaid or other government insurance.
CareConnect4Me helps with insurance coverage questions and enrollment for Jascayd. Call 1-844-527-2293 (1-844-JASCAYD).
CareConnect4Me is Boehringer Ingelheim's support program for Jascayd and Ofev. Boehringer's pages load in the browser only, so offer details were confirmed from Boehringer's own page listings.
Ofev copay program: eligible patients with commercial insurance who enroll in CareConnect4Me may pay as little as $0. Not for Medicare, Medicaid or other government insurance.
CareConnect4Me helps with insurance coverage questions for Ofev. Call 1-866-673-6366. Generic nintedanib capsules were approved in April 2026 and may cost less depending on your plan.
CareConnect4Me is Boehringer Ingelheim's support program for Ofev and Jascayd. Generic nintedanib from several makers was approved on April 2, 2026.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 3 drugmaker programs for Idiopathic Pulmonary Fibrosis medicines and 3 charity funds, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Idiopathic Pulmonary Fibrosis, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 3 funds listed for Idiopathic Pulmonary Fibrosis was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Idiopathic Pulmonary Fibrosis medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund, HealthWell Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
